|
Conference Agenda
Quality
Measurement & Improvement In The
New Medicare Prescription Drug Benefit
|
|
| |
MEETING AGENDA |
|
Date/Time |
Event |
Location |
THURSDAY,
NOVEMBER 17 |
| 8:30AM – 9:45AM |
WELCOME & KEYNOTE
Welcome:
David Schulke
Keynote:
-
Carolyn
M. Clancy, MD, Director, Agency for Healthcare Research & Quality
(AHRQ)
-
Barry
Straube, MD, Acting Chief Medical Officer, Centers
for Medicare & Medicaid Services
|
Regency
EF/Center
(Ballroom
Level)
|
| 9:45AM -
11AM |
STAKEHOLDER PANEL
Panelists include the QIOs, prescription
drug plans, pharmacists, and physicians. Presenters
will give their perspective on what constitutes quality
improvement in the drug benefit, setting the stage
for the discussions throughout the rest of the meeting.
- Michael
Barr, MD, MBA, FACP, Vice President, Practice Advocacy
and Improvement, American College of Physicians
- Judy
Cahill, CEO, Academy of Managed Care Pharmacy
- David
Schulke, Moderator
- Michael
Anderson,
Quality Measurement & Improvement in the New Medicare
Prescription Drug Benefit
|
Regency
EF/Center
(Ballroom
Level)
|
| 11:15AM – 12:30PM |
CONCURRENT SESSIONS 1 - 4 |
|
| |
CONCURRENT SESSION 1: Measures of Quality for a Prescription
Drug Benefit
This session will explore existing measures
that could be a starting point for developing medication-related
quality measures for the Part D benefit, including
the use of measures in public reporting of plan performance.
- Jerry
H. Gurwitz, MD, Executive Director , Meyers Primary
Care Institute
- Stephen
Kogut, PhD, MBA, R.Ph., Assistant Professor of P harmacoepidemiology
and Pharmacoeconomics, University of Rhode Island,
School of Pharmacy
- Fatima
Baysac Millar, CMS Office of Clinical Standards & Quality
- Roland Grieb, MD, MHSA, Health Care Excel, Moderator
|
Potomac
1&2
(Ballroom
Level)
|
| |
CONCURRENT
SESSION 2: MEDICATION THERAPY MANAGEMENT (MTM) PROGRAMS
In
this session, drug plans will discuss their Medication
Therapy Management (MTM) programs, explore the variety
of MTM programs that will be available and discuss
CMS requirements for MTM programs.
|
Potomac
3&4
(Ballroom
Level)
|
| |
CONCURRENT
SESSION 3: HEALTH INFORMATION TECHNOLOGY
Panelists will explore the role of HIT,
including e-prescribing, in ensuring the quality of
prescription drug therapy and improving prescribing
and medication use, especially among the chronically
ill.
- Bruce
Bagley, MD, Medical Director of Quality Improvement,
American Academy of Family Physicians
- Tom
Doerr, MD, Chief Medical Office, Purkinje, Inc.
- Maria
A. Friedman, DBA, Senior Advisor, CMS,
Office of e-Health Standards and Services
|
Potomac
5&6
(Ballroom
Level)
|
| |
CONCURRENT
SESSION 4: CONTINUITY OF CARE
Identify model interventions that link
care across settings, including medication reconciliation.
This panel will focus on post-discharge follow-up and
medication reconciliation.
- Eric
Coleman, MD , Associate Professor of Medicine within
the Divisions of Health Care Policy and Research and
Geriatric Medicine at the University of Colorado Health
Sciences Center
- Fran
Griffin, Director, Institute for Healthcare Improvement
- Steve
Riddle, RPh, BCPS, Harbor View Medical Center
- Sharon
Eloranta , MD, Qualis Health, Moderator
|
Washington
Room
(Ballroom
Level)
|
| 2:00PM – 3:15PM |
CONCURRENT SESSIONS 5 - 8 |
|
| |
CONCURRENT
SESSION 5: MEDICATION ISSUES FOR LONG TERM CARE BENEFICIARIES
Panelists
will explore medication related issues for beneficiaries
in long term care settings.
- Lee
Dobson, MPA, CPHQ, Health Care Quality Assessment,
The Carolinas Center for Medical Excellence, Inc.
- Patrick
O'Reilly, PhD, MPH, Senior Scientist, Research and
Development, MassPRO
- Kevin
Warren , MHA, CPHQ, Vice President, Quality Improvement,
TMF Health Quality Institute
|
Potomac
1&2
(Ballroom
Level)
|
| |
CONCURRENT
SESSION 6:
DELIVERY
OF MTM PROGRAMS IN A COMMUNITY PHARMACY SETTING
This session examines medication therapy
management programs and the various ways in which they
are implemented in the community pharmacy setting.
- Anne
Burns, RPh American Pharmacists Association, Moderator
- Jaime
Hendrickson, PharmD, CDM, Manager, MTM, Albertson's,
Inc.
- Brand
Newland, PharmD, Director of Clinical Services, Outcomes
Pharmaceutical Health Care
- Melissa
Somma, PharmD, University of Pittsburgh/Rite Aid
|
Potomac
3&4
(Ballroom
Level)
|
| |
CONCURRENT
SESSION 7: DATA INTEGRATION
Panelists will explore the opportunities
for improved patient care through the integration of
Medicare Parts A, B, and D data.
- Ben
Eng, MD, MA, Senior Medical Director, Group Leader,
Customer & Markets Development-Medical,
Pfizer Global Pharmaceuticals
- Anita
Franzione, DrPH , Project Manager, Retiree Markets,
Aetna
|
Potomac
5&6
(Ballroom
Level)
|
| |
CONCURRENT
SESSION 8: Disease
State Management by Self-insured Employers
This session will explore an innovative
disease state management program for self-insured employers.
Employers will describe their programs, including the
use of pharmacists to help their employees better manage
their medications.
- William
M. Ellis, RPh, MS
Executive Director / CEO
American
Pharmacists Association Foundation
- Employer representatives being confirmed
|
Washington
Room
(Ballroom
Level)
|
| 3:30PM – 4:45PM |
CONCURRENT
SESSIONS 9 - 11 |
|
| |
CONCURRENT
SESSION 9: INNOVATIVE PATIENT CARE PROGRAMS
QIOs and plans will share models of innovative,
successful patient care programs.
- Patrick
O'Reilly, PhD, MPH, Senior Scientist, Research and
Development, MassPRO
- Mary
Ann Preskul-Ricca, Public Affairs Coordinator, Massachusetts
Association of Health Plans
|
Potomac
1&2 |
| |
CONCURRENT
SESSION 10: HEALTH
INFORMATION TECHNOLOGY
Panelists will explore the role of HIT,
including e-prescribing, in ensuring the quality of
prescription drug therapy and improving prescribing
and medication use, especially among the chronically
ill.
- Kate
Berry, Vice President, Physician and Community Relations,
SureScripts
- Peter
Kaufman, MD, Chief Medical Officer, Dr.First
- Michael
Simko, RPh, Corporate Manager of Pharmacy Health Information
Technology, Walgreens
|
Washington
Room
(Ballroom
Level)
|
| |
CONCURRENT
SESSION 11: MEDICATION THERAPY MANAGEMENT (MTM) PROGRAMS
In this session, drug plans will discuss
their Medication Therapy Management (MTM) programs,
explore the variety of MTM programs that will be available
and discuss CMS requirements for MTM programs.
|
Potomac
3&4
(Ballroom
Level)
|
FRIDAY,
NOVEMBER 18 |
| 8:00AM – 9:00AM |
GENERAL SESSION
This session will focus on health information
technology. Speakers will address current Administration
activities related to e-health regulations and policies,
as well provide an overview of lessons learned from
the development of www.KatrinaHealth.org.
- Kelly
Cronin, Senior Advisor to the Administrator, Centers
for Medicare & Medicaid
Services
- Kevin
Hutchinson, President & CEO, SureScripts
|
Regency
EF/Center
(Ballroom
Level)
|
9:15AM – 11:15AM |
REGIONAL
BREAKOUTS
(REGIONS 1–5)
Provides attendees an opportunity
to network with providers and drug plan sponsors in their state or
region. Participants will discuss what's happening in their area,
including examples of model MTM programs and other quality initiatives.
(1 ½ hours of discussion; ½ hour
to decide what to report out in general session) |
Potomac 1&2
(Ballroom Level) |
| 11:30AM
- 12:30PM |
GENERAL
SESSION
Reports from Regional break out meetings |
Regency
EF/Center
(Ballroom
Level)
|
| 12:30PM – 2:00PM |
LUNCH
AND CLOSING WRAP-UP SESSION
A look at the future of the drug benefit and MTM
programs
Kim
Caldwell, RPh, Senior Director, Corporate Pharmaceutical Outreach/Reimbursement, Abbott |
Regency
EF/Center
(Ballroom
Level) |
|
